Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...
Machine-learning platform enables signal peptide-informed discovery of small molecules that selectively inhibit protein secretion allowing for the degradation of disease-related proteins at the point ...
Enodia employs a large chemical space of inhibitors and a purpose-built library of signal-peptide cell lines.
Advancements in spatial proteomics enable detailed tissue mapping, linking protein localization to disease mechanisms and ...
Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding Enodia Financing co-led by Elaia, Pfizer Ventures and Bpifrance Enodia ...